Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Lifestyle Apparel Line For Cancer Patients Launches Promotion in Memory of Company Founder
  • USA - English


News provided by

Cure Wear

May 11, 2015, 06:00 ET

Share this article

Share toX

Share this article

Share toX

CureWear shirts for patients and supporters
CureWear shirts for patients and supporters

NEW YORK, NEW YORK (PRWEB) May 11, 2015 -- In honor and memory of the company's founder, Alex Niles, CureWear announced an 18 day promotion offering $18 off every item available for purchase on MyCureWear.com. Alex Niles founded CureWear during his own journey with Stage IV Gastric Cancer and while he continually defied the doctors’ expectations given his diagnosis, he passed away on April 8th at the age of 32. He was passionate about making the patient experience more comfortable and finding a way for everyone supporting a cancer patient to feel more inspired.

As Alex’s lucky number was 18, CureWear will offer both patient and supporter shirts at a “lucky” price for 18 days, starting on May 11 through May 28. During this time patient and supporter shirts will be available for $37 (plus shipping and handling). Throughout the promotion, CureWear will continue its giveback program: for every two supporter shirts purchased, CureWear will donate one patient shirt. The company has already donated shirts to two of New York’s largest cancer centers, and to countless individual patients.

  • CureWear Patient and Supporter Shirts now $37 (plus shipping and handling) at MyCureWear.com during promotional period using the code CUREWEAR18
  • Continued Giveback Program of donating 1 patient shirt for every 2 supporter shirts purchased
  • Promotion runs from May 11th through May 28th

CureWear apparel is designed to make life more comfortable for cancer patients being treated via a medical port, allowing them to keep their clothes on during treatment. The patient shirt features a velcro “port accessibility patch” that easily allows nurses the space they need to deliver intravenous treatments via a patient’s medical port. When closed, the port accessibility patch also allows room for medical lines. The CureWear Giveback Program gives 1 patient shirt for every 2 supporter shirts purchased. The company has already donated shirts to two of New York’s largest cancer centers, and to dozens of individual patients.

CureWear launched in August of 2014 with a successful Kickstarter campaign, raising more than $50,000. The campaign grabbed the attention of major media outlets including NBC News and The Huffington Post. The company’s MyCureWear.com went live shortly thereafter, and has expanded to include children’s sizes for both pediatric patients with right-side clavicle ports and kid supporters. In April 2015, CureWear was selected as one of ten finalists in a Shark Tank-style "Future of Wellness Competition" sponsored by Well+Good and FounderMade.

ABOUT CUREWEAR:
CureWear was created by Alex Niles, who was diagnosed with Stage IV Gastric Cancer at the age of 30 in the fall of 2013. As part of his treatment, a medical port was surgically implanted into Alex’s chest. To give nurses access to his medical port, Alex would remove his shirt just before receiving treatment. Alex decided to cut a small hole in an athletic shirt, and create a patch that would allow nurses access to his port, while not requiring him to remove his shirt for treatment. From there, CureWear was born.

To read more about CureWear, visit mycurewear.com. CureWear is also active on Facebook, Instagram and Twitter. Follow for updates about the product, and daily quotes curated by the CureWear team to inspire followers.

ABOUT ALEX NILES:
Alex Niles was the creator and founder of CureWear. An entrepreneur with a background in investment banking, Alex was inspired to create CureWear after his own Stage IV Gastric Cancer diagnosis in the fall of 2013 at the age of 30. As part of his treatment, a medical port was surgically implanted into Alex's chest to administer chemotherapy drugs. Rather than remove his shirt for treatment, Alex cut a small hole into one of his favorite athletic shirts to give nurses access to his port. From there, the idea for CureWear was born. While battling cancer and receiving more than 20 chemotherapy infusions over the course of almost 19 months, Alex created and founded CureWear.

Alex was a graduate of Drexel University, where he was a 4-year Division 1 scholarship athlete on the men's soccer team, and earned a graduate degree from Fordham University. He was recently listed among Drexel's "40 Under 40." Alex wrote about his Cancer experience on his blog, SmilesForNiles.com, and was a regular contributor to The New York Times, Huffington Post, Positively Positive, and Psychology Today.
For more information, please contact info(at)mycurewear(dot)com.
###

CureWear PR, Cure Wear, http://www.mycurewear.com, +1 (610) 937-2498, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.